If the combination can't be prevented, observe teniposide response carefully. Look at therapy modification

This does NOT suggest you might be addicted. Habit is usually a habits associated with finding and using a drug for a nonmedical motive. If the doctor wants you to halt the drugs, the dose will probably be bit by bit decreased eventually in order to avoid any Unwanted side effects.

butabarbital will minimize the extent or effect of almotriptan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

butabarbital will lower the level or result of vardenafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

butabarbital will reduce the extent or impact of nitrendipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Mysterious.

butabarbital improves toxicity of methoxyflurane by increasing metabolism. Contraindicated. Improved metabolism of methoxyflurane to nephrotoxic compounds.

butabarbital will reduce the extent or effect of imatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unfamiliar.

butabarbital will lessen the level or impact of docetaxel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.

butabarbital will lower the level or impact of bosentan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Mysterious.

The subsequent adverse drug reactions and incidences are derived from merchandise labeling Except if in any other case specified.

butabarbital will reduce the level or effect of levamlodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

butabarbital will reduce the extent or result of triamcinolone acetonide injectable suspension by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

Monitor Carefully (2)butabarbital will decrease the level or impact of buprenorphine, extensive-performing injection by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Sufferers who transfer to buprenorphine long-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers should be monitored to ensure buprenorphine plasma click here concentrations are ample.

butabarbital will lessen the extent or influence of etoposide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.